Related Experiment Video
Updated: Aug 7, 2025

06:52
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
Published on: April 30, 2019
17.6K
Reversible Acute Lung Injury due to Bleomycin
Marziyeh Ghalamkari1, Mahdi Khatuni2, Gholamreza Toogeh3
1Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Tanaffos
|March 7, 2023
Summary
Bleomycin-induced lung injury (BILI) is a serious side effect of chemotherapy. Early recognition and high-dose corticosteroid treatment can lead to successful recovery without lasting complications.
Area of Science:
- Oncology
- Pulmonology
- Pharmacology
Background:
- Bleomycin is a cytotoxic antibiotic used for various cancers, including Hodgkin lymphoma.
- Bleomycin-induced lung injury (BILI) is a significant dose-limiting toxicity, with variable incidence and risk factors.
- Clinical presentation of BILI is non-specific, complicating diagnosis and treatment.
Related Concept Videos
Acute Respiratory Failure-II
304
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
304
Pulmonary Cycle: Exhalation
1.7K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
Acute Respiratory Failure-I
269
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
269
Pneumothorax-I
280
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
280
Acute Respiratory Failure-III
242
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
242

